Puberty Blockers Raise Concerns, FDA Warnings

The FDA has added a new warning to the labeling of puberty blockers. It now warns of symptoms such as headaches, nausea, and vision loss. A researcher with the Heritage Foundation has found a correlation between increased suicide rates among young people and states that allow minors access to cross-sex medications without parental consent.

ntd newsletter icon
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
By registering for the newsletter, you agree to the Privacy Policy.